Ignite Creation Date:
2025-12-25 @ 1:42 AM
Ignite Modification Date:
2026-05-22 @ 4:23 PM
Study NCT ID:
NCT05738694
Status:
RECRUITING
Last Update Posted:
2023-05-09
First Post:
2023-01-11
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Neoadjuvant of Axitinib Plus PD-1 to Improve Disease Free Survival of Patients With Renal Cell Carcinoma
Sponsor:
Organization: